Using spatially resolved multi-omic profiling of clinical NPC samples and experimental validation, a tumor-endothelial crosstalk mechanism is identified, driven by the NOTCH1-FTO-SPARC axis. This evidence concerns the gene NOTCH1 and neoplasm.